U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China

kAm%96 f_‑D@>6E9:?8 A2E:6?E 925 6I92FDE65 2== DE2?52C5 =:?6D @7 EC62E>6?E 2E |s p?56CD@? r2?46C r6?E6C :? E96 &?:E65 $E2E6D] w:D 5@4E@CD C64@>>6?565 :G@?6D4:>23[ E96 7:CDE 2AAC@G65 !s‑`^'tvu 3:DA64:7:4 2?E:3@5J 7@C D@=:5 EF>@CD] p7E6C 2 G:56@ 4@?DF=E2E:@? :? =2E6 }@G6>36C D4965F=65 H:E9:? 2 H66< @7 E96:C :?:E:2= :?BF:CJ[ E96 72>:=J 49@D6 y:29F: x?E6C?2E:@?2= r2?46C r6?E6C :? $92?892: 7@C :ED >F=E:5:D4:A=:?2CJ 6IA6CE:D6 2?5 &]$]‑EC2:?65 |65:42= ~?4@=@8J r9:67 sC] )&p} {:?=:]k^Am

kAmsFC:?8 EC62E>6?E[ E96 A2E:6?E 56G6=@A65 :>>F?6‑C6=2E65 4@>A=:42E:@?D C6BF:C:?8 xr& 42C6] %96 42?46C 46?E6C C2A:5=J 4@@C5:?2E65 @?4@=@8J[ ?6FC@=@8J[ 4C:E:42= 42C6[ 2?5 6IA6CE :?AFE 7C@> :G@?6D4:>23 AC:?4:A2= :?G6DE:82E@C sC] +9@F r2:4F?] w:D 4@?5:E:@? 92D D:?46 DE23:=:K65[ H:E9 @?8@:?8 42C6 7@4FD65 @? 5:D62D6 4@?EC@=]k^Am

kAmpD 2 E6CE:2CJ :?E6C?2E:@?2= 9@DA:E2= A2CE?6C65 H:E9 |2DD249FD6EED v6?6C2= w@DA:E2= r2?46C r6?E6C[ y:29F: AC@G:56D D62>=6DD :?E6C?2E:@?2= A2E:6?E A2E9H2JD[ 7C@> C6>@E6 4@?DF=E2E:@?D E@ EC2G6= 4@@C5:?2E:@? 2?5 4@?E:?F@FD 72>:=J FA52E6D]k^Am

kAm%96 A2E:6?EVD 52F89E6C D2:5[ Q(6 2C6 566A=J 8C2E67F= 7@C E96 565:42E:@?[ 4@>A2DD:@?[ 2?5 E:C6=6DD 677@CED @7 E96 6?E:C6 y:29F: E62>i E96 5@4E@CD[ ?FCD6D[ <:E496? 2?5 4=62?:?8 DE277[ E96 :?E6C?2E:@?2= E62> 2?5 7C@?E 56D<[ 2?5 E96 kDA2? :5lQDA2?w89=E6623Qm42C6 2:56Dk^DA2?m] |J 72E96C H@F=5 6DA64:2==J =:<6 E@ 6IAC6DD 9:D 962CE76=E E92?<D E@ kDA2? :5lQDA2?w89=E2d3aQm|D] rF:[ H9@k^DA2?m 92D 42C65 7@C 9:> 6G6CJ 52J D:?46 9:D 25>:DD:@?] q6J@?5 96C 2EE6?E:G6 365D:56 42C6[ D96 92D @776C65 9:> 6?4@FC286>6?E[ 4@>7@CE[ 2?5 9@A6]Qk^Am

kAmr9:?2VD 3C62<E9C@F89 @?4@=@8J :??@G2E:@?D 2C6 4C62E:?8 ?6H @AE:@?D 7@C A2E:6?ED H@C=5H:56] yxrr 4@?E:?F6D E@ 5C2H 8C@H:?8 :?BF:C:6D 2?5 C676CC2=D 7C@> }@CE9 p>6C:42[ tFC@A6[ pD:2 2?5 E96 |:55=6 t2DE[ 6DE23=:D9:?8 $92?892: 2D 2 8=@32= 9F3 7@C 25G2?465 42?46C 42C6]k^Am

kAmkDA2? :5lQDA2?w89=Ef7gaQm%96 7Fk^DA2?m== DE@CJi k2 9C67lQ9EEADi^^;:29F:]4@>^6?^?6HD^`g`Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm9EEADi^^;:29F:]4@>^6?^?6HD^`g`k^2mk^Am

kAmkDEC@?8mr@?E24Eik^DEC@?8mk^Am

kAmkDEC@?8mx?E6C?2E:@?2= !2E:6?E $6CG:46Dk^DEC@?8mk^Am

kAmk2 9C67lQ>2:=E@i:?E6C?2E:@?2=@77:46o;:29F:]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmkDA2? :5lQDA2?w89=Efhb4Qm:?E6Ck^DA2?m?2E:@?2=@77:46o;:29F:]4@>k^2mk^Am

kAm(92EDpAAi Zgda ce`h `h_ck^Am

kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?lr}_baccU2>AjD5la_ae\_b\_eQ ^m ':6H @C:8:?2= 4@?E6?E E@ 5@H?=@25 >F=E:>65:2ik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^FD\A2E:6?E\H:E9\25G2?465\=F?8\42?46C\DE23:=:K65\3J\?@G6=\:>>F?@E96C2AJ\EC62E>6?E\:?\49:?2\b_af_fbfe]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^FD\A2E:6?E\H:E9\25G2?465\=F?8\42?46C\DE23:=:K65\3J\?@G6=\:>>F?@E96C2AJ\EC62E>6?E\:?\49:?2\b_af_fbfe]9E>=k^2mk^Am

kAm$~&#rt y:29F: x?E6C?2E:@?2= w@DA:E2=k^Am

kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lr}_baccU2>Aj%C2?D>:DD:@?0x5la_ae_b_eab`h!#0}t($0&$!#00000r}_baccU2>Ajs2E6x5la_ae_b_eQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am